BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32026767)

  • 1. Stepwise Development of Biomimetic Chimeric Peptides for Gene Delivery.
    Cheraghi R; Nazari M; Alipour M; Hosseinkhani S
    Protein Pept Lett; 2020; 27(8):698-710. PubMed ID: 32026767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel recombinant biomimetic chimeric MPG-based peptide as nanocarriers for gene delivery: Imitation of a real cargo.
    Majidi A; Nikkhah M; Sadeghian F; Hosseinkhani S
    Eur J Pharm Biopharm; 2016 Oct; 107():191-204. PubMed ID: 27368745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery.
    Alipour M; Hosseinkhani S; Sheikhnejad R; Cheraghi R
    Sci Rep; 2017 Jan; 7():41507. PubMed ID: 28128339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors.
    Luo K; He B; Wu Y; Shen Y; Gu Z
    Biotechnol Adv; 2014; 32(4):818-30. PubMed ID: 24389086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic lipid library for gene delivery through thiol-yne click chemistry.
    Li L; Zahner D; Su Y; Gruen C; Davidson G; Levkin PA
    Biomaterials; 2012 Nov; 33(32):8160-6. PubMed ID: 22902058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of the art in peptide-based gene delivery.
    Hadianamrei R; Zhao X
    J Control Release; 2022 Mar; 343():600-619. PubMed ID: 35157938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene delivery.
    Soltani F; Sankian M; Hatefi A; Ramezani M
    Int J Pharm; 2013 Jan; 441(1-2):307-15. PubMed ID: 23200954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector.
    Gonzalez-Fernandez T; Sathy BN; Hobbs C; Cunniffe GM; McCarthy HO; Dunne NJ; Nicolosi V; O'Brien FJ; Kelly DJ
    Acta Biomater; 2017 Jun; 55():226-238. PubMed ID: 28363788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the role of peptides in polymer-based gene delivery.
    Sun Y; Yang Z; Wang C; Yang T; Cai C; Zhao X; Yang L; Ding P
    Acta Biomater; 2017 Sep; 60():23-37. PubMed ID: 28778533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of non-viral gene therapy for CNS disorders.
    Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A designer biomimetic vector with a chimeric architecture for targeted gene transfer.
    Wang Y; Mangipudi SS; Canine BF; Hatefi A
    J Control Release; 2009 Jul; 137(1):46-53. PubMed ID: 19303038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery.
    Bremner KH; Seymour LW; Logan A; Read ML
    Bioconjug Chem; 2004; 15(1):152-61. PubMed ID: 14733595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity.
    Peng LH; Huang YF; Zhang CZ; Niu J; Chen Y; Chu Y; Jiang ZH; Gao JQ; Mao ZW
    Biomaterials; 2016 Oct; 103():137-149. PubMed ID: 27376562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-Enzymatic Synthesis of Linear and Branched Cationic Peptides: Evaluation as Gene Carriers.
    Ageitos JM; Chuah JA; Numata K
    Macromol Biosci; 2015 Jul; 15(7):990-1003. PubMed ID: 25828913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreducible Fluorinated Peptide Dendrimers Capable of Circumventing Various Physiological Barriers for Highly Efficient and Safe Gene Delivery.
    Cai X; Jin R; Wang J; Yue D; Jiang Q; Wu Y; Gu Z
    ACS Appl Mater Interfaces; 2016 Mar; 8(9):5821-32. PubMed ID: 26887907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent patents in cationic lipid carriers for delivery of nucleic acids.
    Koynova R; Tenchov B
    Recent Pat DNA Gene Seq; 2011 Apr; 5(1):8-27. PubMed ID: 21288191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Targeted anti-HER2 scFv Chimeric Peptide for Gene Delivery into HER2-Positive Breast Cancer Cells.
    Cheraghi R; Nazari M; Alipour M; Majidi A; Hosseinkhani S
    Int J Pharm; 2016 Dec; 515(1-2):632-643. PubMed ID: 27825868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components.
    Moritz S; Colin M; Keller M; Klonjkowski B; Capeau J; Coutelle C; Chroboczek J; Brahimi-Horn MC
    Arch Virol; 2003 Jan; 148(1):1-18. PubMed ID: 12536292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides as a material platform for gene delivery: Emerging concepts and converging technologies.
    Urello M; Hsu WH; Christie RJ
    Acta Biomater; 2020 Nov; 117():40-59. PubMed ID: 32966922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.